SEOUL, South Korea, Mar. 23, 2017 /PRNewswire/ -- Hanwha Q CELLS Co., Ltd. ("Hanwha Q CELLS" or the "Company") (NASDAQ: HQCL), a global leading photovoltaic manufacturer of high-performance, high-quality solar modules, today reported its unaudited financial results for the fourth quarter and full year ended December 31, 2016. The Company will host a conference call to discuss the results at 8:00 am Eastern Time (9:00 pm Korea Standard Time) on March 23, 2017.
Fourth Quarter 2016 Highlights
Full Year 2016 Highlights
Mr. Seong-woo Nam, Chairman and CEO of Hanwha Q CELLS, remarked "We achieved record high total module shipment and revenue in the full year 2016 while establishing solid market positioning in key strategic markets in both mature and emerging countries. In 2016, we have also successfully ramped up a world leading PERC cell in-house production capability, now having produced over 3 GW1 of both mono and multi PERC cells since 2015, positioning Hanwha Q CELLS as a global leader in production of advanced cells."
"Despite the market's concern for global solar demands, we have started 2017 with a strong momentum," Mr. Nam continued. "Hanwha Q CELLS was awarded the tender to construct the region's largest 1 GW solar power plant in Turkey, which will help us establish a stronger foothold in the region with great growth potentials, and we have also entered into several large module supply contracts strengthening our sales backlog for the year."
Mr. Jay Seo, CFO of Hanwha Q CELLS, said "Our fourth quarter results came in weaker than anticipated due to certain project schedule delays, which prevented us from recognizing certain revenues in the year 2016, and several other one-time accounting adjustments, such as measurement of inventory at the lower of cost or market and asset impairments." Mr. Seo added, "We will continue to execute on reducing manufacturing costs and augmenting operating expense controls, while diligently managing our balance sheet and cash management."
1 Also includes PERC cells produced by Hanwha Q CELLS Korea Corporation, an affiliate of the Company |
Fourth Quarter 2016 Financial Results
Net Revenues
Gross Profit and Margin
Operating Expense, Income and Margin
Net Interest Expense
Foreign Currency Exchange Gain (Loss)
Gain (loss) on change in Fair Value of Derivative Contracts
Income Tax Expense (Benefit)
Net Income (Loss) and Earnings (Loss) per ADS
Financial Positions
As of December 31, 2016, the Company had cash and cash equivalents of $390.9 million, compared with $254.8 million as of September 30, 2016. The restricted cash as of December 31, 2016 was $108.1 million, compared with $147.2 million as of September 30, 2016.
As of December 31, 2016, accounts receivable was $415.1 million, compared with $453.1 million as of September 30, 2016. Inventories were $333.5 million as of December 31, 2016, compared with $451.7 million as of September 30, 2016.
Total short-term bank borrowings (including the current portion of long-term bank borrowings) were $527.9 million as of December 31, 2016, an increase of $113.0 million from the third quarter of 2016. As of December 31, 2016, the Company had total long-term debt (net of current portion and long-term notes) of $643.7 million, a decrease of $153.2 million from the third quarter of 2016. The Company's long-term bank and government borrowings are to be repaid in installments until their maturities, which range from one to fourteen years.
Net cash provided by operating activities was $94.8 million in the fourth quarter of 2016.
Capital expenditures were $25.1 million in the fourth quarter of 2016.
Full Year 2016 Financial Results
Net Revenues
Gross Profit and Margin
Operating Expense, Income and Margin
Net Interest Expense
Foreign Currency Exchange Gain (Loss)
Gain (loss) on change in Fair Value of Derivative Contracts
Income Tax Expense (Benefit)
Net Income (Loss) and Earnings (Loss) per ADS
Financial Positions
As of December 31, 2016, the Company had cash and cash equivalents of $390.9 million, compared with $200.0 million as of December 31, 2015. The restricted cash as of December 31, 2016 was $108.1 million, compared with $172.2 million in the previous year.
As of December 31, 2016, accounts receivable was $415.1 million, compared with $641.9 million as of December 31, 2015. Inventories were $333.5 million, compared with $406.1 million as of December 31, 2015.
Total short-term bank borrowings (including the current portion of long-term bank borrowings) were $527.9 million as of December 31, 2016, an increase of $111.2 million from the full year of 2015. As of December 31, 2016, the Company had total long-term debt (net of current portion and long-term notes) of $643.7 million, a decrease of $9.8 million from the full year of 2015. The Company's long-term bank and government borrowings are to be repaid in installments until their maturities, which range from one to fourteen years.
Net cash provided by operating activities was $125.5 million in the full year 2016.
Capital expenditures were $137.7 million in the full year 2016.
Operations Updates
Production Capacity
As of December 31, 2016, the Company's in-house, annualized production capacities were 1,550 MW for ingot, 950 MW for wafer, 4,150 MW for cell and 4,150 MW for module.
Additionally, the Company has an access of module supply of up to 1,550 MW (annualized) as of December 31, 2016 from Hanwha Q CELLS Korea Corporation, an affiliate of the Company.
Business Outlook
First Quarter and Full Year 2017 Guidance
For the first quarter of 2017, the Company estimates net revenues in the range of $410 to 430 million.
For the full year 2017, the Company estimates:
Conference Call
The Company will host a conference call to discuss the results at 8:00 am Eastern Time (9:00 pm Korea Standard Time) on March 23, 2017. The management will discuss the results and take questions following the prepared remarks.
A live webcast of the conference call will be available on the investor relations section of the Company's website at http://investors.hanwha-qcells.com or by clicking the following hyperlink: http://edge.media-server.com/m/p/5wtyqxo3.
The dial-in details for the live conference call are as follows:
International Toll Free Dial-In Number |
+65 67135090 |
United States |
+1 (845) 675-0437 |
South Korea |
+82 (0)2 6490-3660 |
Germany |
08001820671 |
China, Domestic Hong Kong |
8008190121 / 4006208038 +852 30186771 |
Passcode: HQCL
A replay of the call will be available after the conclusion of the conference call on the investor relations section of the Company's website at www.hanwha-qcells.com and also by dialing numbers below:
International Toll Free Dial-In Number |
+61 2 8199 0299 |
United States |
+1 (855) 452-5696 |
South Korea |
0079861361602 |
Germany |
08001802149 |
China, Domestic Hong Kong |
8008700206 / 4006322162 800963117 |
Conference ID 83925129
Replay time period: March 23, 2017 11:00 ET - March 31, 2017 08:59 ET
About Hanwha Q CELLS
Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is one of the worlds largest and most recognized photovoltaic manufacturers for its high-performance, high-quality solar cells and modules. It is headquartered in Seoul, South Korea (Global Executive HQ) and Thalheim, Germany (Technology & Innovation HQ), with diverse international manufacturing facilities in Malaysia and China. Hanwha Q CELLS offers the full spectrum of photovoltaic products, applications and solutions, from modules to kits to systems to large scale solar power plants. Through its growing global business network spanning Europe, North America, Asia, South America, Africa and the Middle East, the company provides excellent services and long-term partnership to its customers in the utility, commercial, government and residential markets. Hanwha Q CELLS is a flagship company of Hanwha Group, a FORTUNE Global 500 firm and a Top 10 business enterprise in South Korea. For more information, visit: http://www.hanwha-qcells.com/.
Safe Harbor Statement
This report contains forward-looking statements that are not statements of historical fact. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Such statements, particularly statements about our guidance for performance in the first quarter and the full year 2017, involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in Hanwha Q CELLS' filings with the Securities and Exchange Commission, including its annual report on Form 20-F. Except as required by law, Hanwha Q CELLS does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Hanwha Q CELLS Co., Ltd. |
|||||||||||
Unaudited Condensed Consolidated Balance Sheets |
|||||||||||
(in millions of US dollars, except share data) |
|||||||||||
December 31, |
September 30, |
December 31, |
|||||||||
ASSETS |
(unaudited) |
(unaudited) |
(audited) |
||||||||
Current assets |
|||||||||||
Cash and cash equivalents |
390.9 |
254.8 |
200.0 |
||||||||
Restricted cash |
108.1 |
147.2 |
172.2 |
||||||||
Accounts and notes receivable - net |
330.8 |
327.0 |
365.1 |
||||||||
Receivables from related parties |
84.3 |
126.1 |
276.8 |
||||||||
Inventories |
333.5 |
451.7 |
406.1 |
||||||||
Loans to related parties |
13.0 |
120.0 |
47.8 |
||||||||
Other current assets |
80.1 |
101.4 |
102.7 |
||||||||
Total current assets |
1,340.7 |
1,528.2 |
1,570.7 |
||||||||
Long-term prepayments |
- |
1.9 |
2.6 |
||||||||
Fixed assets - net |
758.4 |
822.6 |
877.3 |
||||||||
Intangible assets - net |
12.2 |
18.5 |
14.8 |
||||||||
Land use rights - net |
52.3 |
49.7 |
51.8 |
||||||||
Deferred tax assets - net |
0.6 |
(0.4) |
0.8 |
||||||||
Loans to related parties |
3.0 |
3.0 |
9.3 |
||||||||
Other long-term assets |
31.5 |
24.0 |
20.2 |
||||||||
Total assets |
2,198.7 |
2,447.5 |
2,547.5 |
||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||||||||
Current liabilities |
|||||||||||
Accounts payable |
199.8 |
142.2 |
226.1 |
||||||||
Notes payable |
107.2 |
140.0 |
129.0 |
||||||||
Payables to related parties |
128.7 |
247.4 |
169.0 |
||||||||
Loans from related parties |
- |
- |
32.4 |
||||||||
Deferred revenue |
18.9 |
24.9 |
402.1 |
||||||||
Accrued expenses |
36.6 |
41.9 |
41.8 |
||||||||
Other payables |
22.7 |
20.4 |
25.0 |
||||||||
Tax payables |
16.0 |
20.2 |
0.2 |
||||||||
Short-term debt |
407.4 |
404.1 |
255.6 |
||||||||
Current portion of long-term debt |
120.5 |
10.8 |
161.1 |
||||||||
Customer deposits |
17.3 |
31.9 |
7.0 |
||||||||
Unrecognized tax benefit |
- |
- |
17.9 |
||||||||
Derivative contracts |
- |
10.6 |
0.8 |
||||||||
Litigation accruals |
0.2 |
1.7 |
5.9 |
||||||||
Deferred tax liabilities |
2.4 |
1.1 |
5.7 |
||||||||
Warranty provision |
42.2 |
43.8 |
43.6 |
||||||||
Other current liabilities |
6.3 |
4.7 |
7.3 |
||||||||
Total current liabilities |
1,126.2 |
1,145.7 |
1,530.5 |
||||||||
Long-term debt |
643.7 |
796.9 |
653.5 |
||||||||
Long-term warranty provision |
19.0 |
20.7 |
17.4 |
||||||||
Deferred tax liabilities |
7.2 |
6.7 |
5.9 |
||||||||
Total liabilities |
1,796.1 |
1,970.0 |
2,207.3 |
||||||||
Redeemable ordinary shares |
- |
- |
- |
||||||||
Stockholders' equity |
|||||||||||
Ordinary shares |
0.4 |
0.4 |
0.4 |
||||||||
Additional paid-in capital |
431.7 |
431.8 |
431.1 |
||||||||
Accumulated income (deficit) |
99.8 |
125.7 |
(20.2) |
||||||||
Accumulated other comprehensive loss |
(129.3) |
(80.4) |
(71.1) |
||||||||
Total stockholders' equity |
402.6 |
477.5 |
340.2 |
||||||||
Total liabilities, redeemable ordinary shares and stockholders' equity |
2,198.7 |
2,447.5 |
2,547.5 |
Hanwha Q CELLS Co., Ltd. |
||||||||||||
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) |
||||||||||||
(in millions of US dollars, except share data and net income (loss) per share) |
||||||||||||
For the three months ended |
For the twelve months ended |
|||||||||||
Dec 31, 2016 |
Sep 30, 2016 |
Dec 31, 2015 |
Dec 31, 2016 |
Dec 31, 2015 |
||||||||
(unaudited) |
(unaudited) |
(unaudited) |
(unaudited) |
(audited) |
||||||||
Net sales |
565.9 |
707.8 |
702.1 |
2,426.6 |
1,800.8 |
|||||||
Cost of goods sold |
511.9 |
567.3 |
567.9 |
1,971.9 |
1,466.8 |
|||||||
Gross profit |
54.0 |
140.5 |
134.2 |
454.7 |
334.0 |
|||||||
Selling and marketing expenses |
27.9 |
36.4 |
36.3 |
120.2 |
94.1 |
|||||||
General and administrative expenses |
20.3 |
19.7 |
30.2 |
77.6 |
91.7 |
|||||||
Research and development expenses |
11.9 |
12.0 |
13.9 |
49.4 |
48.3 |
|||||||
Restructuring charges |
- |
- |
- |
- |
22.0 |
|||||||
Operating income (loss) |
(6.1) |
72.4 |
53.8 |
207.5 |
77.9 |
|||||||
Other income (expenses) |
||||||||||||
Interest income |
3.1 |
0.1 |
4.5 |
8.1 |
10.9 |
|||||||
Interest expense |
(15.3) |
(12.5) |
(22.9) |
(54.8) |
(66.9) |
|||||||
Foreign exchange gain (loss) |
(7.5) |
(2.3) |
(6.6) |
(4.0) |
(23.6) |
|||||||
Gain (loss) on change in fair value of derivative contracts |
7.0 |
(2.1) |
(0.7) |
(24.1) |
9.6 |
|||||||
Investment income (loss) |
0.8 |
(0.6) |
(0.4) |
(1.2) |
(1.9) |
|||||||
Other income (expense) - net |
(12.9) |
(3.0) |
2.9 |
(10.2) |
(0.6) |
|||||||
Reversal of litigation accruals |
- |
- |
- |
- |
48.5 |
|||||||
Other expense, net |
(24.8) |
(20.4) |
(23.2) |
(86.2) |
(24.0) |
|||||||
Income (loss) before income tax |
(30.9) |
52.0 |
30.6 |
121.3 |
53.9 |
|||||||
Income tax expense (benefit) |
(5.4) |
10.3 |
4.6 |
0.8 |
10.1 |
|||||||
Net income (loss) |
(25.5) |
41.7 |
26.0 |
120.5 |
43.8 |
|||||||
Net income (loss) attributable to Hanwha Q CELLS Co., Ltd.'s stockholders per share: |
||||||||||||
Basic |
(US$0.01) |
US$0.01 |
US$0.01 |
US$0.03 |
US$0.01 |
|||||||
Diluted |
(US$0.01) |
US$0.01 |
US$0.01 |
US$0.03 |
US$0.01 |
|||||||
Net income (loss) attributable to Hanwha Q CELLS Co., Ltd.'s stockholders per ADS: |
||||||||||||
Basic |
(US$0.31) |
US$0.50 |
US$0.31 |
US$1.45 |
US$0.53 |
|||||||
Diluted |
(US$0.31) |
US$0.50 |
US$0.31 |
US$1.45 |
US$0.53 |
|||||||
Number of shares used in computation of net income (loss) per share: |
||||||||||||
Basic |
4,159,051,773 |
4,159,051,773 |
4,158,755,035 |
4,158,984,882 |
4,120,369,328 |
|||||||
Diluted |
4,159,287,244 |
4,159,514,634 |
4,159,506,708 |
4,159,297,541 |
4,120,689,668 |
|||||||
Number of shares used in computation of net income (loss) per ADS: |
||||||||||||
Basic |
83,181,035 |
83,181,035 |
83,175,101 |
83,179,698 |
82,407,387 |
|||||||
Diluted |
83,185,745 |
83,190,293 |
83,190,134 |
83,185,951 |
82,413,793 |
|||||||
Other comprehensive income (loss) |
||||||||||||
Foreign currency translation adjustment |
(48.9) |
(2.0) |
39.0 |
(58.2) |
(34.6) |
|||||||
Comprehensive income (loss) |
(74.4) |
39.7 |
65.0 |
62.3 |
9.2 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hanwha-q-cells-reports-fourth-quarter-and-full-year-2016-results-300428351.html